June 2012
The essential resource for your practice
Volume XXI, Number 6

AUA Nominates Dahm, Klein for Task Force

Earlier this year, the Agency for Healthcare Research and Quality (AHRQ) issued a call for nominations for new members to serve on the U.S. Preventive Services Task Force. Recognizing a strong need for urology representation on this increasingly controversial panel, the AUA submitted two nominations: Dr. Philipp Dahm, of the University of Florida and Dr. Eric Klein of the Cleveland Clinic Foundation. 

Table of Contents


Coding Corner:

CMS Defers Implementation Date for New NMP22 Code

AUA Responds to USPSTF Recommendations on PSA Testing

On May 21, 2012, during the AUA Annual Meeting, the U.S. Preventive Services Task Force (USPSTF) released final recommendations against prostate-specific antigen (PSA)-based screening for prostate cancer, asserting that there is "moderate or high certainty that the service has no net benefit or that the harms outweigh the benefits," and discouraged the use of the test by issuing it a Grade D rating.

The AUA issued its response as soon as the recommendations were made public, and joined other urology groups (including the American Association of Clinical Urology, the Large Urology Group Practice Association, the Society of University Urologists and the Society of Urologic Oncology) in making a public statement at a special event during the Annual Meeting. Representatives from the groups were also joined by Mr. Scott Johnson, who represented the Prostate Cancer Roundtable, a coalition of patient groups, and Dr. William Catalona, who co-authored a response that appeared in Annals of Internal Medicine along with the USPSTF recommendations. 

For The Record

The Centers for Medicare and Medicaid Services (CMS) published a Notice of Proposed Rulemaking (NPRM) document on March 7, 2012, on their recommended changes to the EHR Incentive Program measures for Stage 2. The complete text of the rule can be found at Federal Register NPRM on MU.

 In the executive summary of the rule, CMS explained their intent to “specify Stage 2 criteria that eligible providers (EPs), eligible hospitals, and critical access hospitals (CAHs) must meet in order to qualify for an incentive payment, as well as introduce changes to the program timeline and detail payment adjustments”. 

AUA Applauds Rep. Brett Guthrie for Support Of Urotrauma Research, Education and Training

In April, U.S. Congressman Brett Guthrie (R-KY-02) testified before the House Armed Services Committee in support of increased awareness of combat-related genitourinary injuries, or urotrauma. In his testimony, Congressman Guthrie advocated for the inclusion of H.R. 1612 – a bill that specifically addresses urotrauma and calls for the establishment of a commission to study the long-term effects of these devastating conditions – into this year’s Department of Defense (DoD) authorization bill. The AUA, who has been the  driving force behind the urotrauma bill, immediately hailed Rep. Guthrie’s testimony. 

"We applaud Rep. Guthrie and the federal government for taking an increased interest and focus on genitourinary trauma," said AUA Vice Chair of Health Policy David F. Penson, MD, MPH. "Urotrauma may not be as visible as other war injuries, but it can be every bit as devastating to the quality of a soldier's life and well being. It is imperative that we take steps to ensure that medical staff are thoroughly trained to adequately treat these injuries on the battlefield and beyond to maximize outcomes."